First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

Organon today announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), published the results of the RUBY study which reached its primary effectiveness outcome of successfully treating abnormal postpartum uterine bleeding and postpartum hemorrhage with the JADA® System.

What are the potential long-term effects on healthcare and the economy due to decreased STEMI treatment during the COVID-19 pandemic?

Researchers predicted long-term health consequences and expenses associated with ST-elevation myocardial infarction (STEMI) treatment during the first COVID-19 lockdown.

June 20, 2023

Intellia suggests ATTR amyloidosis gene editing treatment has over a year of durability as it gears up for PhIII

Intellia on Thursday presented new results for its gene editing treatment in 65 patients with ATTR amyloidosis — a condition in which misfolded proteins build

November 3, 2023

M&A: ResMed Acquires Somnoware to Expand Sleep Management Offerings

by Fred Pennic 07/05/2023 Leave a Comment What You Should Know: ResMed, the #1 global producer of CPAP machines and masks to treat sleep apnea

July 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.